EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Targeting the Spinal Cord‐Brain Axis: Electroacupuncture Mitigates Remote Frontal Cortex Neuroinflammation via HMGB1/TLR4 to Aid Functional Recovery After Spinal Cord Injury

Yu Ning, Xin Hao, Phattharapon Rattanasakon, Yifei Dong, Ying Yang, Keduo Liu, Yuting Lin, Suhua Shi iD, Yuping Mo, Zhigang Li

Brain and Behavior · 2026-01 · 16 (1)

DOI: 10.1002/brb3.71215 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Brain and Behavior, online erschienen am 19.01.2026. Verfasst von Yu Ning und 9 weiteren Autor:innen. Beteiligte Einrichtung: School of Acupuncture, Moxibustion and Tuina, Beijing University of Chinese Medicine, Beijing, China. Hauptthemen laut MEDLINE: Spinal Cord Injuries, Electroacupuncture, HMGB1 Protein, Toll-Like Receptor 4. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 40 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Natural Science Foundation of China, Shenzhen High-level Hospital Construction Fund.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Beyond the primary lesion, spinal cord injury (SCI) induces secondary neuroinflammation in the frontal cortex, a critical factor exacerbating neural damage and impeding functional recovery. This remote inflammatory response is predominantly regulated by the HMGB1/TLR4 signaling pathway. While electroacupuncture (EA) shows therapeutic promise, whether its efficacy is causally dependent on modulating this supraspinal inflammation remains unproven. This study investigated whether EA promotes functional recovery by suppressing the HMGB1/TLR4/NF‐κB pathway in the frontal cortex of rats with SCI.

Methods

One hundred and fifty adult male rats were randomly assigned to Sham, SCI, EA, SCI+ HMGB1 Inhibitor (I), and SCI + EA + HMGB1 Inhibitor (EA + I) groups. Functional recovery was assessed at 1, 7, 14, and 28 days post‐SCI using Basso, Beattie, and Bresnahan (BBB) scores and the inclined plate test. Frontal cortex tissue was analyzed at 7, 14, and 28 days post‐injury for proteins in the HMGB1/TLR4/NF‐κB pathway, TNF‐α (via Western blot and immunofluorescence), and microglial activation (Iba‐1 via immunofluorescence). The mRNA levels of these targets were assessed by qPCR at 7 and 28 days. Spinal cord tissue was evaluated for axonal integrity (NF200 via immunofluorescence) and for motor neuron survival (Nissl staining) at 28 days post‐injury.

Results

EA treatment significantly improved locomotor and postural recovery compared to the SCI group. Concurrently, EA suppressed the SCI‐induced upregulation of HMGB1, TLR4, NF‐κB, and TNF‐α in the brain throughout the subacute (Day 7), transition (Day 14), and chronic (Day 28) phases, thereby inhibiting microglial activation. This neuroprotective effect was accompanied by spinal motor neuron survival and axonal integrity. The co‐administration of an HMGB1 inhibitor with EA established the pathway's necessity by showing that the resulting potentiation of therapeutic outcomes positions the HMGB1/TLR4/NF‐κB axis as a central mechanism for EA.

Conclusion

EA effectively ameliorates motor dysfunction following SCI by attenuating neuroinflammation in the frontal cortex. The underlying mechanism is causally linked to the downregulation of the HMGB1/TLR4/NF‐κB signaling axis. The enhanced neuroprotection observed when combining EA with HMGB1 inhibition validates this signaling axis as the primary and essential target for EA's therapeutic effects in SCI management.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Spinal Cord InjuriesElectroacupunctureHMGB1 ProteinToll-Like Receptor 4Recovery of FunctionFrontal LobeNeuroinflammatory DiseasesAnimalsMaleRatsRats, Sprague-DawleySignal TransductionNF-kappa BSpinal CordMicrogliaInflammation

Stichwörter der Autor:innen

HMGB1/TLR4 /NF‐κB pathwayelectroacupuncturemicroglial activationmotor neuron survivalneuroinflammationspinal cord injury

Substanzen

HMGB1 ProteinToll-Like Receptor 4Tlr4 protein, ratNF-kappa BHbp1 protein, rat

Autor:innen und Institutionen

  • School of Acupuncture, Moxibustion and Tuina, Beijing University of Chinese Medicine, Beijing, China.
  • Department of Rehabilitation, The Third Affiliated Hospital of Beijing University of Chinese Medicine, Beijing, China.
  • College of Clinical Medicine, Hainan Vocational College of Medicine, Haikou, China.
  • Traditional Chinese Medicine Department, Shenzhen Third People's Hospital, Southern University of Science and Technology, Shenzhen, China.

ORCID-Profile: Suhua Shi

Förderung

  • National Natural Science Foundation of China
  • Shenzhen High-level Hospital Construction Fund

Zitieren

APA

Ning, Y., Hao, X., Rattanasakon, P., Dong, Y., Yang, Y., Liu, K., Lin, Y., Shi, S., Mo, Y., & Li, Z. (2026). Targeting the Spinal Cord‐Brain Axis: Electroacupuncture Mitigates Remote Frontal Cortex Neuroinflammation via HMGB1/TLR4 to Aid Functional Recovery After Spinal Cord Injury. Brain and Behavior, 16(1). https://doi.org/10.1002/brb3.71215

Vancouver

Ning Y, Hao X, Rattanasakon P, Dong Y, Yang Y, Liu K, et al. Targeting the Spinal Cord‐Brain Axis: Electroacupuncture Mitigates Remote Frontal Cortex Neuroinflammation via HMGB1/TLR4 to Aid Functional Recovery After Spinal Cord Injury. Brain and Behavior. 2026;16(1). doi:10.1002/brb3.71215

BibTeX
@article{Ning2026,
  author = {Ning, Yu and Hao, Xin and Rattanasakon, Phattharapon and Dong, Yifei and Yang, Ying and Liu, Keduo and Lin, Yuting and Shi, Suhua and Mo, Yuping and Li, Zhigang},
  title = {Targeting the Spinal Cord‐Brain Axis: Electroacupuncture Mitigates Remote Frontal Cortex Neuroinflammation via HMGB1/TLR4 to Aid Functional Recovery After Spinal Cord Injury},
  journal = {Brain and Behavior},
  year = {2026},
  volume = {16},
  number = {1},
  doi = {10.1002/brb3.71215}
}
Kostenlos starten →